₹850.25
▲ +10.08 +1.20%
16 Jul 2026
NSE Listed
Windlas Biotech Limited (WINDLAS)
Volume: 84,991Avg Vol 1W: 50,733Avg Vol 1M: 46,596.3552W Range:₹697.4₹1,097.9
Key Ratios
Checked 15h agoMarket Cap₹1,734 Cr
Current Price₹850.25
Previous Close₹840.17
High / Low (52w)₹1,097.9 / ₹697.4
Volume84,991
Avg Vol (1W)50,733
Avg Vol (1M)46,596.35
Stock P/E110.84
Book Value₹281.35
Dividend Yield75%
ROE11.44%
ROA7.32%
Revenue (TTM)₹922 Cr
Revenue Growth20.4%
Profit Margin7.35%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹5
EPS (TTM)₹32.2
P/B2.99
Debt / Equity0.06
50 DMA₹827.34
200 DMA₹821.39
Day change+1.20%
Price Chart
₹850.25▼ 9.11% · 1Y
2025-07-162026-07-15
20-day avg volume: 47K shares
Pros
- Pays a dividend yield of 75.0%.
- Company is almost debt-free.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 111.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹175 Cr | ₹187 Cr | ₹195 Cr | ₹203 Cr | ₹210 Cr | ₹222 Cr | ₹233 Cr | ₹239 Cr |
| EBITDA | ₹19 Cr | ₹21 Cr | ₹22 Cr | ₹22 Cr | ₹24 Cr | ₹25 Cr | ₹21 Cr | ₹22 Cr |
| Net Profit | ₹13 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹18 Cr | ₹18 Cr | ₹15 Cr | ₹16 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹312 Cr | ₹331 Cr | ₹431 Cr | ₹473 Cr | ₹523 Cr | ₹644 Cr | ₹778 Cr | ₹922 Cr |
| EBITDA | ₹32 Cr | ₹35 Cr | ₹45 Cr | ₹47 Cr | ₹58 Cr | ₹78 Cr | ₹84 Cr | ₹92 Cr |
| Net Profit | ₹64 Cr | ₹16 Cr | ₹16 Cr | ₹38 Cr | ₹43 Cr | ₹58 Cr | ₹61 Cr | ₹66 Cr |
| EPS | 37.65 | 8.9 | 8.7 | 18.58 | 19.7 | 27.88 | 28.87 | 31.15 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹298 Cr | ₹338 Cr | ₹296 Cr | ₹491 Cr | ₹529 Cr | ₹626 Cr | ₹760 Cr | ₹907 Cr |
| Total Liabilities | ₹105 Cr | ₹129 Cr | ₹97 Cr | ₹96 Cr | ₹127 Cr | ₹176 Cr | ₹255 Cr | ₹327 Cr |
| Equity | ₹194 Cr | ₹210 Cr | ₹199 Cr | ₹395 Cr | ₹402 Cr | ₹450 Cr | ₹506 Cr | ₹581 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹31 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr | ₹71 Cr | ₹128 Cr | ₹89 Cr | ₹120 Cr |
| Investing | ₹-5 Cr | ₹-14 Cr | ₹-20 Cr | ₹-155 Cr | ₹-14 Cr | ₹-92 Cr | ₹-74 Cr | ₹-92 Cr |
| Financing | ₹-6 Cr | ₹-5 Cr | ₹1 Cr | ₹130 Cr | ₹-44 Cr | ₹-15 Cr | ₹1 Cr | ₹-13 Cr |
| Free Cash Flow | ₹31 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr | ₹71 Cr | ₹128 Cr | ₹89 Cr | ₹120 Cr |
Shareholding
Promoter 63.31% Institutions 11.19% Public 25.5%
Efficiency & Working Capital
ROCE14.9%
Interest Coverage19
Dividend Payout—
Debtor Days92 d
Inventory Days25 d
Payable Days96 d
Cash Conversion Cycle20 d
Working Capital Days117 d
Shareholding Details
As of 2026-05-31
Promoter63.3%
FII1%
DII10.2%
Institutions11.2%
Public25.5%
Promoter Pledge0%
No. of Shareholders46,084
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 | May 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 62.8% | 62.8% | 62.5% | 62.5% | 62.5% | 62.3% | 62.3% | 62% | 62% | 61.9% | 63.3% | 63.3% |
| FIIs | 1.4% | 1.2% | 1.6% | 2% | 1.6% | 1.5% | 1.4% | 1.1% | 0.9% | 0.6% | 1% | 1% |
| DIIs | 11.7% | 11.8% | 10.3% | 9.6% | 10.3% | 10.9% | 11.2% | 11.4% | 11.4% | 11.8% | 10.2% | 10.2% |
| Public | 24.1% | 24.2% | 25.6% | 25.9% | 25.7% | 25.3% | 25% | 25.5% | 25.6% | 25.7% | 25.5% | 25.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 61,900 | 51,277 | 45,824 | 45,706 | 46,590 | 46,383 | 45,887 | 45,433 | 45,461 | 44,769 | 46,084 | 46,084 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Akw Wbl Family Private Trust (through Its Trustees Ashok Vimla Trusteeship Services Private Limited) | Shareholding of Promoter and Promoter Group | 40.6% | 83,81,340 |
| Ashok Kumar Windlass | Shareholding of Promoter and Promoter Group | 21.3% | 44,00,000 |
| Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) Fund | Public Shareholding | 4.4% | 9,13,135 |
| Vimla Windlasss | Shareholding of Promoter and Promoter Group | 1.4% | 2,84,000 |
| Mncl Capital Compounder Fund 2 | Public Shareholding | 1.2% | 2,53,000 |
| Ajay Kumar Aggarwal | Public Shareholding | 1.2% | 2,49,138 |
| Bandhan Small Cap Fund | Public Shareholding | 1.2% | 2,42,521 |
| Perpetuity Health To Wealth (h2w) Rising Fund | Public Shareholding | 1.1% | 2,15,840 |
| Ashok Kumar Windlass Family Trust | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Vimla Windlass Family Trust | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Windlas Foundation | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Windlas Exports Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Wintech Eco Solutions Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ashok Vimla Trusteeship Services Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Hitesh Windlass | Shareholding of Promoter and Promoter Group | 0% | 3 |
| Manoj Kumar Windlass | Shareholding of Promoter and Promoter Group | 0% | 3 |
| Payal Windlass | Shareholding of Promoter and Promoter Group | 0% | 3 |
| Prachi Jain Windlass | Shareholding of Promoter and Promoter Group | 0% | 3 |
| Vani Windlass Shukla | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rhiditya Windlass | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Atharv Windlass | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Abha Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ankur Jain | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Richa Mittal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Ayann Windlass | Shareholding of Promoter and Promoter Group | 0% | 0 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Ashok Kumar Windlass | 0 | 0% | 2026-05-26 |
| Vimla Windlasss | 0 | 0% | 2026-05-26 |
| Hitesh Windlass | 0 | 0% | 2026-05-26 |
| Manoj Kumar Windlass | 0 | 0% | 2026-05-26 |
| Payal Windlass | 0 | 0% | 2026-05-26 |
| Prachi Jain Windlass | 0 | 0% | 2026-05-26 |
| Vani Windlass Shukla | 0 | 0% | 2026-05-26 |
| Rhiditya Windlass | 0 | 0% | 2026-05-26 |
| Atharv Windlass | 0 | 0% | 2026-05-26 |
| Abha Jain | 0 | 0% | 2026-05-26 |
| Ankur Jain | 0 | 0% | 2026-05-26 |
| Richa Mittal | 0 | 0% | 2026-05-26 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Vivek Dhariwal | Chairman & Independent Directo | 2026 |
| ASHOK KUMAR WINDLASS | WTD & Executive Director | 2026 |
| MANOJ KUMAR WINDLASS | Joint MD & Executive Director | 2026 |
| HITESH WINDLASS | Executive Director & MD | 2026 |
| Gaurav Gulati | Independent Non Exe. Director | 2026 |
| Prachi Jain Windlass | Non Executive Director | 2026 |
| Pawan Kumar Sharma | Executive Director | 2026 |
| Tarashree Singhal | Independent Non Exe. Director | 2026 |
| Ananta Narayan Panda | Company Sec. & Compli. Officer | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceutical | ₹0 Cr | — |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹5 | 54 | 11 | 11 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-16 | Dividend (6.3/- per share) | Final |
| dividend | 2026-07-16 | ₹6.3 (126%) | Final |
| buyback | 2026-05-07 | ₹1000 max | — |
| dividend | 2025-07-21 | ₹5.8 (116%) | Final |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 18 | 5 | 23 |
| 2026 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026 | 0 | 0 | 0 | 14 | 5 | 19 |
Company Information
🌐 www.windlasbiotech.com ↗
📍 40/1 Mohabewala Industrial, Area, Dehradun, Uttarakhand, 248110
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search